• Episode 6 - Interview with Ann Jordan, CEO of ASQ
    Jan 30 2023
    Host Jim Fries speaks to Ann Jordan, CEO of The American Society of Quality (ASQ), about recent changes in quality management since the COVID-19 pandemic. Ann discusses how these quality changes impact supply chain and data integrity in the pharmaceutical industry, and how quality professionals adapt and react to challenges in the workforce, technology, and risk management.
    Show More Show Less
    31 mins
  • Episode 5 - Interview with Best-Selling Author Katherine Eban
    Jul 15 2022
    Host Jim Fries speaks to Katherine Eban, contributing editor for Vanity Fair and a New York Times best-selling author, in the fifth episode of The Patient Safety Podcast. Eban walks Fries through her investigation into the criminal underbelly of generic drug manufacturing that eventually led to writing her best-selling book, Bottle of Lies: The Inside Story of the Generic Drug Boom. Discover what it takes to expose criminals in the global pharmaceutical world, and what lessons the industry has learned since Eban’s investigation.
    Show More Show Less
    23 mins
  • Episode 4 - Interview with Leigh Verbois, Director of the Office of Drug Security, Integrity, and Response for the FDA
    Jun 7 2022
    Host Jim Fries speaks to Leigh Verbois, the Director of the Office of Drug Security, Integrity, and Response for the FDA, in the fourth episode of The Patient Safety Podcast. The episode covers Verbois’ time developing the APEC Toolkit designed to assist pharmaceutical companies in rooting out bad actors in the supply chain. Listen in on the conversation between Fries and Verbois on how collaboration, communication, and innovation are the keys to improving supply chain security. Thank you to Rx-360: https://rx-360.org/ Thank you to our guest Leigh Verbois: https://www.linkedin.com/in/leigh-verbois-8b12316/
    Show More Show Less
    22 mins
  • Episode 3 - Interview with Ron Piervincenzi, CEO of The United States Pharmacopeia
    Apr 7 2022
    Host Jim Fries speaks to Ron Piervincenzi, Ph.D., CEO of the United States Pharmacopeia (USP), in the third episode of The Patient Safety Podcast. The episode covers topics such as Piervincenzi’s time at USP, the company’s 200-year history of developing standards, and the way those standards were put to the test during the COVID-19 pandemic. Listen in on the conversation about fostering innovation in the pharmaceutical supply chain and keeping patients safe. Thank you to Rx-360: https://rx-360.org/ Thank you to our guest Dr. Ron Piervincenzi: https://www.linkedin.com/in/ronald-piervincenzi-558b7a8/
    Show More Show Less
    24 mins
  • Episode 2 - Interview with Janet Woodcock, Principal Deputy Commissioner of the FDA
    Feb 24 2022
    Host Jim Fries speaks to Dr. Janet Woodcock, Principal Deputy Commissioner of the FDA, in the second episode of The Patient Safety Podcast. Originally recorded on January 19th, 2022 when Dr. Janet Woodcock was the acting FDA commissioner, the episode covers topics such as Woodcock’s experience in the FDA and how the FDA reassessed the pharmaceutical supply chain during the COVID-19 Pandemic. Listen in on the conversation about pharmaceutical best practices and patient safety in the most ordinary to the most extreme cases. Thank you to Rx-360: https://www.linkedin.com/company/rx-360 Thank you to our guest Janet Woodcock: https://www.fda.gov/about-fda/fda-organization/janet-woodcock
    Show More Show Less
    21 mins
  • Episode 1 - Interview with Martin Van Trieste, CEO of Civica Rx
    Jan 17 2022
    Host Jim Fries, CEO of Rx-360, speaks to Martin Van Trieste, President and CEO of Civica Rx in the first episode of the Patient Safety Podcast. Covering topics such as the origin story of Rx-360 and the podcast’s mission to protect patient safety by sharing information, the two industry leaders explore relevant issues in the pharmaceutical ecosystem. Listen in on Van Trieste and Fries’ conversation about security in the global supply chain. Find out why criminals exploit the pharmaceutical industry—and how ensuring patient safety in the creation and distribution of pharmaceuticals requires executives, suppliers, and distributors to work collaboratively and proactively. Thank you to Rx-360: https://rx-360.org/ Thank you to our guest Martin Van Trieste: https://www.linkedin.com/in/mvantrieste/
    Show More Show Less
    32 mins